Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma

Liver

Volumn 22, Issue 2, 2002, Pages 145-149

  Ito, Yasuhiro ^a,b   Takeda, Tsutomu ^a   Sasaki, Yo ^c   Sakon, Masato ^b   Yamada, Terumasa ^c   Ishiguro, Shingo ^c   Imaoka, Shingi ^c   Tsujimoto, Masahiko ^d   Monden, Morito ^b   Matsuura, Nariaki ^b,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Cholangiocellular carcinoma; Immunohistochemistry; p57 bile duct carcinoma

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN P57;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CELL ACTIVITY; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DIVISION; CHOLANGIOCARCINOMA; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P57; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NUCLEAR PROTEINS;

EID: 0036268330     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2002.01532.x     Document Type: Article

References (18)

1. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression
2. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct
3. Prognostic value of the cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma
4. p21 is a universal inhibitor of cyclin kinases
5. p27/Kip 1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
6. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
7. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors
8. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene
9. Reduced expression of the cyclin-dependent kinase inhibitor gene p57kip2 in Wilms' tumor
10. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.5
11. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5
12. kip1 expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma
13. Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma
14. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct
15. Immunohistochemical characterization of p57/KIP2 expression in human esophageal squamous cell carcinoma
16. High level expression of p27Kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27Kip1 and degree of malignancy in human breast and colorectal cancers